Eton Pharmaceuticals Inc

NASDAQ:ETON   3:59:53 PM EDT
2.14
+0.04 (+1.90%)
Mergers / Acquisitions

Eton Pharmaceuticals Announces Acquisition Of FDA-Approved Rare Disease Product

Published: 09/13/2022 13:37 GMT
Eton Pharmaceuticals Inc (ETON) - Eton Pharmaceuticals Announces Acquisition of FDA-approved Rare Disease Product, Betaine Anhydrous for Oral Solution.
Eton Pharmaceuticals Inc - Expect Transaction to Be Accretive to 2023 Earnings.